Skip to main content
. 2021 Aug 23;61(11):640–646. doi: 10.2176/nmc.oa.2021-0137

Table 4. IV rt-PA administration and change in occluded site in sequential imaging.

Distal change in occluded site in sequential imaging (Group A) (n = 55) No change in occluded site in sequential imaging (Group B) (N = 148) P value
IV rt-PA 0.5
Yes (n = 103) 30 73
No (n = 100) 25 75
Time interval between IV rt-PA and DSA 7.7 (n = 30) 8.6 (n = 73) 0.7
Time interval between randomization and DSA 21.1 20.9 0.9

IV: intravenous, rt-PA: recombinant tissue plasminogen activator.